Zomep

Zomep

omeprazole

Manufacturer:

Drug International

Distributor:

ECE Pharma

Marketer:

Jazmark
Concise Prescribing Info
Contents
Omeprazole Na
Indications/Uses
Duodenal ulcer, gastric ulcer, NSAID-associated gastric & duodenal ulcers or erosions, H. pylori eradication in PUD, reflux esophagitis, symptomatic GERD, acid-related dyspepsia, Zollinger­-Ellison syndrome & patients considered to be at risk of aspiration of gastric contents during general anesth/acid aspiration prophylaxis.
Dosage/Direction for Use
40 mg over 20-30 min IV infusion or slow IV inj.
Contraindications
Hypersensitivity to omeprazole & substituted benzimidazoles. Concomitant use w/ nelfinavir.
Special Precautions
Possibility of malignancy should be excluded prior treatment. Gastric carcinoma. May cause false -ve results in urea breath test for H. pylori infection. Hepatic impairment. Pregnancy.
Adverse Reactions
Headache, diarrhea & skin rashes. Pruritis, dizziness, fatigue, constipation, nausea & vomiting, flatulence, abdominal pain, arthralgia & myalgia, urticaria, & dry mouth.
Drug Interactions
May prolong the elimination of diazepam, phenytoin & warfarin. Reduced absorption of drugs eg, dasatinib, ketoconazole & itraconazole. May increased plasma conc w/ voriconazole. Reduced exposure of atazanavir.
MIMS Class
Antacids, Antireflux Agents & Antiulcerants
ATC Classification
A02BC01 - omeprazole ; Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Presentation/Packing
Form
Zomep lyo powd for inj 40 mg
Packing/Price
(w/ 0.9% sodium chloride diluent in amp) 10 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in